No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
The Vanilloid Receptor TRPV1 (Transient Receptor Potential Vanilloid 1) is a receptor found in the peripheral nervous system that is involved in the detection of pain and temperature. It is a target for analgesic drugs, which are used to reduce pain. Analgesics that target TRPV1 are known as TRPV1 agonists, and they work by activating the receptor to reduce pain signals. TRPV1 agonists are used to treat a variety of conditions, including chronic pain, neuropathic pain, and inflammatory pain.
The TRPV1 agonist market is a growing area of research and development, with many companies investing in the development of new drugs. Companies such as Pfizer, Merck, and Johnson & Johnson are researching and developing TRPV1 agonists for the treatment of pain. Other companies such as Novartis, GlaxoSmithKline, and AstraZeneca are also researching and developing TRPV1 agonists for the treatment of pain. Show Less Read more
